The ADC binds HER2 on tumor cells, is internalized, and releases MMAE, which then binds the beta‑tubulin (vinca domain) to inhibit microtubule polymerization, causing G2/M arrest and apoptosis in HER2-positive cells; beta‑tubulin itself is not the targeting determinant.